Stemless Reverse Shoulder Arthroplasty Grants Satisfactory Clinical Scores at Minimum 5 Year Follow-up: Comparative Study.

Reverse shoulder arthroplasty complications stemless stemmed

Journal

Journal of shoulder and elbow arthroplasty
ISSN: 2471-5492
Titre abrégé: J Shoulder Elb Arthroplast
Pays: United States
ID NLM: 101763114

Informations de publication

Date de publication:
2024
Historique:
received: 22 05 2024
revised: 02 08 2024
accepted: 23 09 2024
medline: 28 10 2024
pubmed: 28 10 2024
entrez: 28 10 2024
Statut: epublish

Résumé

To compare outcomes, between stemmed and stemless reverse shoulder arthroplasty (RSA) at a minimum follow-up of 5 years. The authors retrospectively assessed a consecutive series of 45 patients that underwent RSA between September 2014 and October 2018 (23 stemless and 22 stemmed). All patients underwent plain anteroposterior and scapular Y-view radiographs for assessment immediately post-operatively and at final follow-up. At a minimum follow-up of 5 years, an independent observer assessed the clinical scores, including Constant score, QuickDASH score, and American Shoulder and Elbow Surgeons score. Of the 45 patients that underwent RSA, 5 patients died (11%), 2 were revised due to infection (4%), and 4 patients were lost to follow-up (9%). This left a final cohort of 34 patients (18 stemless and 16 stemmed). Significant differences between groups were found immediately post-operatively for lateralisation shoulder angle (LSA) (p = 0.021), but at 5 years post-operative for distalisation shoulder angle (DSA) (p = 0.017) and QuickDASH scores (p = 0.041) (Table 4), while the outcomes were comparable for absolute Constant scores, ASES score, and range of motion. Finally, stemless RSA had a 17% complication rate, while stemmed RSA had a 31% complication rate. Stemless RSA had significantly more lateralisation, and significantly less distalisation, compared to stemmed RSA. Furthermore, at a 5-year follow-up, stemless RSA granted significantly greater QuickDASH scores. Finally, stemless RSA had comparable complication rates as stemmed RSA. The clinical relevance of this study is that stemless RSA is a safe alternative to stemmed RSA, while granting comparable or greater scores.

Identifiants

pubmed: 39463777
doi: 10.1177/24715492241291315
pii: 10.1177_24715492241291315
pmc: PMC11503698
doi:

Types de publication

Journal Article

Langues

eng

Pagination

24715492241291315

Informations de copyright

© The Author(s) 2024.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Alexandre Quemener (A)

University of Franche Comte, Medical School & University Hospital Besançon, SINERGIES, Besançon, France.

Alizé Dabert (A)

University of Franche Comte, Medical School & University Hospital Besançon, SINERGIES, Besançon, France.

Séverin Rochet (S)

University of Franche Comte, Medical School & University Hospital Besançon, SINERGIES, Besançon, France.

Adam Antoine (A)

University of Franche Comte, Medical School & University Hospital Besançon, SINERGIES, Besançon, France.

Astrid Pozet (A)

CHU de Besançon, Delegation for Clinical Research and Innovation, Besançon, France.

Geoffroy Nourissat (G)

Clinique Maussins Nollet, Ramsay Santé, Paris, France.
Clinique Saint Jean de Dieu, Paris, France.

Maxime Antoni (M)

Clinique de l'Orangerie, ELSAN, Strasbourg, France.

Howard Harris (H)

Texas Orthopedic Specialists, PLLC, Bedford, USA.

Chinyelum Agu (C)

ReSurg SA, Nyon, Switzerland.

Laurent Obert (L)

University of Franche Comte, Medical School & University Hospital Besançon, SINERGIES, Besançon, France.

Classifications MeSH